Kamada (KMDA) Receivables (2012 - 2026)
Kamada (KMDA) reported Receivables of $40.7 million for Q1 2026, up 19.94% on a YoY basis from $33.9 million in Q1 2025, and up 24.46% quarter-over-quarter from $32.7 million in Q4 2025.
Kamada (KMDA) Receivables (2012 - 2026) Analysis & Trends
Kamada has reported Receivables for 15 years, with the latest figure at $40.7 million in Q1 2026.
- For the quarter ending Q1 2026, Receivables rose 19.94% year-over-year to $40.7 million; the trailing twelve-month figure through Mar 2026 stood at $40.7 million (up 19.94% YoY), and the FY2025 full-year result was $32.7 million, up 20.56% from the prior year.
- Receivables for Q1 2026 stood at $40.7 million, up from $32.7 million in the prior quarter.
- The five-year high for Receivables was $40.7 million in Q1 2026, with the low at $24528.0 in Q1 2023.
- Historically, Receivables has averaged $26.6 million across 5 years, with a median of $27.7 million in 2023.
- Annual changes were most pronounced in 2023 — Receivables plunged 99.92% — and 2024, when it surged 102908.81%.
- Kamada's Receivables stood at $36.0 million in 2022, then slipped by 28.14% to $25.8 million in 2023, then advanced by 4.84% to $27.1 million in 2024, then climbed by 20.56% to $32.7 million in 2025, then increased by 24.46% to $40.7 million in 2026.
- The last three Receivables figures came in at $40.7 million (Q1 2026), $32.7 million (Q4 2025), and $35.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 3.39 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 1.51 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 312.00 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 31.29 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 768.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1.15 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 407.63 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 149.62 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 355.67 Mn |
| 10 | Kamada | 504.70 | -73.15 Mn | 19.12 Mn | 40.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.65 Mn |
| Dec 31, 2025 | 32.66 Mn |
| Sep 30, 2025 | 35.32 Mn |
| Jun 30, 2025 | 35.21 Mn |
| Mar 31, 2025 | 33.89 Mn |
| Dec 31, 2024 | 27.09 Mn |
| Sep 30, 2024 | 20.85 Mn |
| Jun 30, 2024 | 31.17 Mn |
| Mar 31, 2024 | 25.27 Mn |
| Dec 31, 2023 | 25.84 Mn |
| Sep 30, 2023 | 26.76 Mn |
| Jun 30, 2023 | 27.66 Mn |
| Mar 31, 2023 | 24,528.00 |
| Dec 31, 2022 | 35.96 Mn |
| Sep 30, 2022 | 30,881.00 |
| Jun 30, 2022 | 24.15 Mn |
| Mar 31, 2022 | 29.44 Mn |
| Dec 31, 2021 | 44.03 Mn |
| Sep 30, 2021 | 30.94 Mn |
| Jun 30, 2021 | 30.19 Mn |